We are live on ! Find out more
B

Bellecapital Portfolio holdings

AUM $625M Turnover 41.45%
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+8.11%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$413M
AUM Growth
+$11.4M
Cap. Flow
-$24.5M
Cap. Flow %
-5.92%
Top 10 Hldgs %
36.22%
Holding
202
New
10
Increased
37
Reduced
56
Closed
42
Avg Time Held
3.1 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
2.1 years

Sector Composition

Rank Sector Weight
1 Technology 28.01%
2 Miscellaneous 15.15%
3 Consumer Staples 12.57%
4 Healthcare 11.71%
5 Consumer Discretionary 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NIO icon
151
NIO
NIO
$8.59B
$157K 0.04%
16,253
– –
2022 Q4
2 quarters
AMN icon
152
AMN Healthcare
AMN
$1.57B
– –
-3,340
Closed -$277K –
ARCB icon
153
ArcBest
ARCB
$2.91B
– –
-4,001
Closed -$370K –
ARTNA icon
154
Artesian Resources
ARTNA
$345M
– –
-6,249
Closed -$346K –
BHP icon
155
BHP
BHP
$212B
– –
-8,100
Closed -$514K –
BOX icon
156
Box
BOX
$5.43B
– –
-8,364
Closed -$224K –
BRBR icon
157
BellRing Brands
BRBR
$1.1B
– –
-9,650
Closed -$328K –
CHRW icon
158
C.H. Robinson
CHRW
$16.3B
– –
-4,044
Closed -$402K –
CI icon
159
Cigna
CI
$79.9B
– –
-1,019
Closed -$260K –
COCO icon
160
Vita Coco
COCO
$3.4B
– –
-18,150
Closed -$356K –
COHR icon
161
Coherent
COHR
$45.9B
– –
-5,316
Closed -$202K –
COP icon
162
ConocoPhillips
COP
$176B
– –
-3,840
Closed -$381K –
CRL icon
163
Charles River Laboratories
CRL
$14.3B
– –
-24,237
Closed -$4.89M –
CRUS icon
164
Cirrus Logic
CRUS
$5.41B
– –
-2,670
Closed -$292K –
EA icon
165
DELISTED
Electronic Arts
EA
– –
-1,720
Closed -$207K –
GD icon
166
General Dynamics
GD
$93.1B
– –
-1,313
Closed -$300K –
GPC icon
167
Genuine Parts
GPC
$18.5B
– –
-2,035
Closed -$340K –
GPK icon
168
Graphic Packaging
GPK
$2.54B
– –
-13,436
Closed -$342K –
HCAT icon
169
Health Catalyst
HCAT
$130M
– –
-19,242
Closed -$225K –
MDLZ icon
170
Mondelez International
MDLZ
$81.6B
– –
-3,876
Closed -$270K –
MRNA icon
171
Moderna
MRNA
$87B
– –
-1,540
Closed -$237K –
NEM icon
172
Newmont
NEM
$125B
– –
-5,000
Closed -$245K –
NVT icon
173
nVent Electric
NVT
$23B
– –
-6,500
Closed -$279K –
OKE icon
174
Oneok
OKE
$58.8B
– –
-5,701
Closed -$362K –
PLTR icon
175
Palantir
PLTR
$447B
– –
-12,450
Closed -$105K –

Similar funds

Bellecapital's Q2 2023 Portfolio in Review

As of Q2 2023, Bellecapital held 202 positions worth $413M, up 2.8% from $402M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Bellecapital withdrew a net $24.5M in Q2 2023, closing 42 positions and reducing 56 holdings. Its most notable exit was Charles River Laboratories, an estimated $4.89M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 23% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Bellecapital opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $6.35M.

  • Bellecapital's largest Q2 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 84,622 shares worth $6.35M.
  • Bellecapital added most to Arista Networks in Q2 2023, an estimated $8.62M increase.
  • Bellecapital's biggest Q2 2023 reduction was PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund, cutting an estimated $4.23M.
  • Bellecapital fully exited Charles River Laboratories in Q2 2023, selling an estimated $4.89M.
  • Bellecapital's ten largest holdings make up 36% of its $413M portfolio in Q2 2023.
  • Bellecapital opened 10 new positions and closed 42 in Q2 2023.
  • Bellecapital's portfolio value rose 2.8% quarter-over-quarter to $413M.

Based on Bellecapital's 13F filing for Q2 2023, filed 7 Jul 2023.